IL17A and metabolic dysfunction-associated steatohepatitis: In agreement with this observation, Tang et al. reported a greater IL-17+ cell infiltration in liver tissue of NASH patients compared to control subjects, using immunohistochemical analyses, and also described increased liver mRNA expression of IL-17 and other Th17-related cytokines, such as IL-21 and IL-23 [88].